From AI Biomarkers to Digital Twins: The Future of Imaging-Driven Drug Development

Session details:

Advanced analytics are enabling researchers to move beyond measuring disease to predicting outcomes. From AI-derived biomarkers to digital twins, emerging technologies are creating new opportunities to forecast treatment response, model disease progression, and support more informed development decisions. Key Topics: Building predictive models using multimodal imaging and clinical datasets The role of AI-enabled biomarkers in oncology drug development Digital twins and their potential application in clinical development Forecasting treatment response and disease progression Separating future promise from current real-world application